Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol-Myers Squibb	$59.53 -2.4%	$58.64	$39.35 ▼ $63.33	$121.13B	0.43	12.73 million shs	9.61 million shs
ET Energy Transfer	$18.73 +0.7%	$19.43	$14.90 ▼ $21.45	$64.25B	1.72	14.57 million shs	11.18 million shs
T AT&T	$28.49 +0.7%	$25.82	$15.94 ▼ $28.61	$204.47B	0.56	36.28 million shs	43.97 million shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol-Myers Squibb	+1.58%	-0.07%	+2.25%	+7.94%	+12.58%
ET Energy Transfer	-0.61%	-1.37%	-3.70%	-5.05%	+18.25%
T AT&T	+0.46%	+5.08%	+3.21%	+24.40%	+60.94%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BMY Bristol-Myers Squibb	3.8832 of 5 stars	1.2	3.0	4.2	4.0	3.5	3.3	0.0
ET Energy Transfer	4.1486 of 5 stars	3.5	4.0	1.7	0.0	3.4	0.0	3.1
T AT&T	4.6269 of 5 stars	2.4	5.0	3.3	3.7	3.3	0.8	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMY Bristol-Myers Squibb	2.33	Hold	$57.86	-2.81% Downside
ET Energy Transfer	2.91	Moderate Buy	$22.09	17.98% Upside
T AT&T	2.78	Moderate Buy	$27.21	-4.47% Downside

Current Analyst Ratings Breakdown

Latest T, ET, and BMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/1/2025	T AT&T	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$27.00 ➝ $32.00
3/31/2025	T AT&T	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$28.00 ➝ $32.00
3/25/2025	ET Energy Transfer	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$23.00 ➝ $23.00
3/25/2025	ET Energy Transfer	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$20.00 ➝ $26.00
3/24/2025	ET Energy Transfer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/19/2025	T AT&T	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$27.00 ➝ $28.00
3/4/2025	ET Energy Transfer	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/3/2025	T AT&T	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$26.00 ➝ $28.50
2/25/2025	ET Energy Transfer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
2/13/2025	T AT&T	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$28.50
2/12/2025	ET Energy Transfer	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$21.00 ➝ $23.00

(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMY Bristol-Myers Squibb	$48.30B	2.51	$6.28 per share	9.48	$8.08 per share	7.37
ET Energy Transfer	$82.67B	0.78	$2.62 per share	7.14	$12.29 per share	1.52
T AT&T	$122.34B	1.67	$5.63 per share	5.06	$16.47 per share	1.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMY Bristol-Myers Squibb	-$8.95B	-$4.42	N/A	9.78	2.07	-18.53%	13.93%	2.46%	4/24/2025 (Estimated)
ET Energy Transfer	$4.39B	$1.28	14.63	12.32	0.64	5.74%	11.56%	3.90%	5/6/2025 (Estimated)
T AT&T	$10.95B	$1.49	19.12	12.55	3.00	8.95%	13.97%	4.16%	4/23/2025 (Estimated)

Latest T, ET, and BMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	BMY Bristol-Myers Squibb	$1.55	N/A	N/A	N/A	$10.77 billion	N/A
4/23/2025	N/A	T AT&T	$0.52	N/A	N/A	N/A	$30.39 billion	N/A
2/11/2025	Q4 2024	ET Energy Transfer	$0.35	$0.29	-$0.06	$0.29	$21.41 billion	N/A
2/6/2025	Q4 2024	BMY Bristol-Myers Squibb	$1.47	$1.67	+$0.20	$0.04	$11.57 billion	N/A
1/27/2025	Q4 2024	T AT&T	$0.48	$0.54	+$0.06	$0.56	$31.94 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMY Bristol-Myers Squibb	$2.48	4.17%	+6.38%	N/A	17 Years
ET Energy Transfer	$1.30	6.94%	+27.86%	101.56%	N/A
T AT&T	$1.11	3.90%	-18.89%	74.50%	N/A

Latest T, ET, and BMY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/3/2025	BMY Bristol-Myers Squibb	quarterly	$0.62	4.14%	4/4/2025	4/4/2025	5/1/2025
3/21/2025	T AT&T	quarterly	$0.2775	3.94%	4/10/2025	4/10/2025	5/1/2025
1/27/2025	ET Energy Transfer	quarterly	$0.3250	6.4%	2/7/2025	2/7/2025	2/19/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMY Bristol-Myers Squibb	2.90	1.25	1.15
ET Energy Transfer	1.42	1.12	0.88
T AT&T	1.00	0.66	0.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMY Bristol-Myers Squibb	76.41%
ET Energy Transfer	38.22%
T AT&T	57.10%

Insider Ownership

Company	Insider Ownership
BMY Bristol-Myers Squibb	0.09%
ET Energy Transfer	3.28%
T AT&T	0.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMY Bristol-Myers Squibb	34,300	2.03 billion	2.03 billion	Optionable
ET Energy Transfer	12,600	3.43 billion	3.32 billion	Optionable
T AT&T	160,700	7.18 billion	7.17 billion	Optionable

T, ET, and BMY Headlines

Recent News About These Companies

Oppenheimer Boosts AT&T (NYSE:T) Price Target to $32.00

April 1 at 1:40 PM | marketbeat.com

AT&T Inc. (T) Completes Significant Global Notes Offering

April 1 at 1:27 PM | gurufocus.com

AT&T Internet Air

April 1 at 1:13 PM | uk.pcmag.com

AT&T (NYSE:T) Trading Up 0.6% Following Analyst Upgrade

April 1 at 11:20 AM | marketbeat.com

AT&T's FirstNet expands coverage, now connecting "roughly 60 Empire State Buildings"

April 1 at 8:11 AM | phonearena.com

Geode Capital Management LLC Has $3.72 Billion Holdings in AT&T Inc. (NYSE:T)

April 1 at 6:20 AM | marketbeat.com

AT&T Inc. (NYSE:T) Shares Bought by StoneX Group Inc.

April 1 at 6:10 AM | marketbeat.com

National Bank of Canada FI Buys 547,466 Shares of AT&T Inc. (NYSE:T)

April 1 at 5:59 AM | marketbeat.com

B. Metzler seel. Sohn & Co. AG Sells 169,519 Shares of AT&T Inc. (NYSE:T)

April 1 at 5:43 AM | marketbeat.com

Alliancebernstein L.P. Acquires 5,329,647 Shares of AT&T Inc. (NYSE:T)

April 1 at 5:33 AM | marketbeat.com

Women’s Final Four In Tampa Set, AT&T Brings The Energy

April 1 at 3:11 AM | forbes.com

AT&T (NYSE:T) Shares Up 0.6% on Analyst Upgrade

April 1 at 1:19 AM | marketbeat.com

NWSL, AT&T ink exclusive sponsorship deal as 2025 season kicks off

March 31 at 5:08 PM | sportsbusinessjournal.com

AT&T goes the NWSL way with its latest announcement

March 31 at 5:08 PM | phonearena.com

Promised discounts vanished - now this AT&T customer is facing a bill they can't pay

March 31 at 5:08 PM | phonearena.com

My Honest Review of AT&T's Cheapest Internet Plan

March 31 at 5:08 PM | cnet.com

AT&T Inc (T)'s Uncertain Future: Understanding the Barriers to Outperformance

March 31 at 1:18 PM | gurufocus.com

Where Will AT&T Stock Be in 1 Year?

March 31 at 12:45 PM | fool.com

Citigroup Increases AT&T (NYSE:T) Price Target to $32.00

March 31 at 12:00 PM | marketbeat.com

AT&T (NYSE:T) Stock Price Up 0.6% After Dividend Announcement

March 31 at 11:34 AM | marketbeat.com

Here is What to Know Beyond Why AT&T Inc. (T) is a Trending Stock

March 31 at 10:05 AM | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality

T, ET, and BMY Company Descriptions

Bristol-Myers Squibb NYSE:BMY

$59.53 -1.46 (-2.39%)

Closing price 03:59 PM Eastern

Extended Trading

$59.74 +0.21 (+0.35%)

As of 05:05 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Energy Transfer NYSE:ET

$18.73 +0.14 (+0.73%)

Closing price 03:59 PM Eastern

Extended Trading

$18.74 +0.01 (+0.05%)

As of 05:04 PM Eastern

Energy Transfer LP provides energy-related services. The company owns and operates natural gas transportation pipeline, and natural gas storage facilities in Texas and Oklahoma; and approximately 20,090 miles of interstate natural gas pipeline. It also sells natural gas to electric utilities, independent power plants, local distribution and other marketing companies, and industrial end-users. In addition, the company owns and operates natural gas gathering pipelines, processing plant, and treating and conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, Ohio, Oklahoma, Arkansas, Kansas, Montana, North Dakota, Wyoming, and Louisiana; natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas; and transports and supplies water to natural gas producer in Pennsylvania. Further, it owns 5,700 miles of natural gas liquid (NGL) pipeline; NGL fractionation facilities; NGL storage facilities; and other NGL storage assets and terminal. Additionally, the company provides crude oil transportation, terminalling, acquisition, and marketing activities; owns and operates approximately 14,500 miles of crude oil trunk and gathering pipelines in the Southwest, Midcontinent, and Midwest United States; and sells and distributes gasoline, middle distillate, and motor fuels and other petroleum products. It also offers natural gas compression services; carbon dioxide and hydrogen sulfide removal services; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalty, and generate electrical power. The company was formerly known as Energy Transfer Equity, L.P. and changed its name to Energy Transfer LP in October 2018. Energy Transfer LP was founded in 1996 and is headquartered in Dallas, Texas.

AT&T NYSE:T

$28.48 +0.21 (+0.72%)

Closing price 03:59 PM Eastern

Extended Trading

$28.50 +0.01 (+0.04%)

As of 05:04 PM Eastern

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time